RECOMMENDATIONS FOR COVID-19 PREVENTION AND TESTING FOR HEMATOPOIETIC CELL TRANSPLANT CENTERS IN BRAZIL

September 2023

Autores

  • Ana Verena de Almeida Mendes Hospital São Rafael, Universidade Baiana, Brazil
  • Fabianne Carlesse Universidade Federal de São Paulo - UNIFESP/EPM, Brazil
  • Jessica Ramos Hospital Sírio Libanês
  • Márcia Garnica Maiolin Universidade Federal do Rio de Janeiro, Complexo Hospitalar de Niterói, Brazil
  • clarisse martins machado Universidade de São Paulo

DOI:

https://doi.org/10.46765/2675-374X.2023v4n3p206

Resumo

From February 2020 to May 2023, 37,625,916 cases of COVID-19 were recorded in Brazil, which led to 2,173,359 hospitalizations due to severe acute respiratory syndrome (SARS) with 703,291 deaths due to COVID-19. More than 14 million cases were registered in 2021 and 2022. However, there was a significant drop in the number of hospitalizations for SARS and the COVID-19 fatality rate in 2022, which certainly reflects the impact of mass vaccination in the country, started in February 2021.

Downloads

Publicado

17/10/2023

Como Citar

Mendes, A. V. de A. ., Carlesse, F. ., Ramos, J., Garnica Maiolin, M. ., & machado, C. M. (2023). RECOMMENDATIONS FOR COVID-19 PREVENTION AND TESTING FOR HEMATOPOIETIC CELL TRANSPLANT CENTERS IN BRAZIL : September 2023. JBMTCT, 4(3), 206. https://doi.org/10.46765/2675-374X.2023v4n3p206

Edição

v. 4 n. 3 (2023): Journal of Bone Marrow Transplantation and Cellular Therapy

Seção

Artigos

Licença

Copyright (c) 2023 JBMTCT

Creative Commons License

Este trabalho está licenciado sob uma licença Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.